Solutions > Clinical Registries > Immunology and Rheumatology

Immunology and Rheumatology

Longitudinal, multi-source, curated registries, offering rapid access to deep clinical data, insights and outcomes.

Immunology and Rheumatology Registries

Multiple Sclerosis

Rheumatoid Arthritis

Juvenile Idiopathic Arthritis

Ankylosing Spondylitis




Other inflammatory


  OM1’s Immunology & Rheumatology data reach

Outcomes for RA Patients on Biological DMARDs

  RA patients benefit greatly from the initiation of Biological DMARDs within the first 2 months after start date.

To view outcome scores for individual DMARDs, contact us to get started.

Insights & Outcomes in Near-Real Time

  • Comparative Treatment Benefits
  • Treatment Patterns
  • Therapy Switching
  • Care Pathways
  • Disease Activity
  • Risks of Disease Progression
  • Prescriber Patterns
  • Off-Label Use
  • Dynamics of Use
  • Responders
  • Market Trends
  • Competitive Intelligence


Deep Clinical Data

Using cutting-edge technology, OM1 empowers the healthcare industry to access, analyze, and use deeper data in a more robust and clinically meaningful way.

Findings From A Real-World Cohort

AI and Big Data provide a unique opportunity to support clinical development, real-world evidence, value and commercialization strategies. Download this report to learn more about real-world applications.

Get Started